Globe Newswire
DODGEVILLE, Wis., May 22, 2024 (GLOBE NEWSWIRE) -- Lands' End, Inc. (NASDAQ: LE) will host a conference call at 8:30 a.m. Eastern Time on Wednesday, June 5, 2024, to discuss its first quarter 2024 financial results. A news release containing these results will be issued before the call. Listeners may access a live broadcast of the conference call on the Company’s investor relations website: http://investors.landsend.com/ in the Events and Presentations section.
An... (continue reading...)
DODGEVILLE, Wis., May 22, 2024 (GLOBE NEWSWIRE) -- Lands' End, Inc. (NASDAQ: LE) will host a conference call at 8:30 a.m. Eastern Time on Wednesday, June 5, 2024, to discuss its first quarter 2024 financial results. A news release containing these results will be issued before the call. Listeners may access a live broadcast of the conference call on the Company’s investor relations website: http://investors.landsend.com/ in the Events and Presentations section.
An... (continue reading...)
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITYRule 8.5 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Name of exempt principal trader:HSBC Bank Plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeWood Group (John) plc(c) Name of the party to the offer... (continue reading...)DUBLIN and SHANGHAI, May 22, 2024 (GLOBE NEWSWIRE) -- PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD), today announced its unaudited financial results for the first quarter ended March 31, 2024.
First Quarter 2024 Highlights
- Total revenues in the quarter were RMB86,812.1 million (US$112,023.3 million), an increase of 131% from RMB37,637.1 million in the same quarter of 2023.
- Operating profit in the quarter was RMB25,973.7 million (US$3,597.3... (continue reading...)
RESEARCH TRIANGLE PARK, N.C. and SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Deimos Biosciences, a portfolio company of Jupiter Bioventures, announced a global licensing agreement (excluding the Asia-Pacific region) for lerociclib for radioprotective uses. Lerociclib is a potent and selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). Such inhibitors can increase the... (continue reading...)
More Globe Newswire
View Older Stories-
Wallbridge Drilling at Fenelon Intersects Near Surface High-Grade Gold Mineralization
-
Photronics Reports Second Quarter Fiscal 2024 Results
-
Parsons Selected For LAWA’s Capital Improvement Program MATOC
-
Form 8.3 - Mattioli Woods
-
Formula Systems Reports First Quarter 2024 Financial Results
-
Form 8.3 - Lok’n Store Group PLC
-
Form 8.3 - Keywords Studios Plc
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
HSBC - DEALINGS DISCLOSURE - XP Power Limited
-
Form 8.3 - Alpha Financial Markets Consulting Plc
-
Scatec ASA: Mandatory notification of trade by primary insider
-
Fingrid to collect grid service fees from July until December
-
CorVel Announces Revenues and Earnings
-
Xinyuan Real Estate Co., Ltd. Releases 2023 Annual Report, Achieving Positive Net Profit Attributable to Shareholders
-
Wizz Air and Striim partnership will streamline mission-critical operations with real-time data pipelines
-
Hooker Furnishings to Host First Quarter Earnings Call June 6th
-
Dycom Industries, Inc. Announces Fiscal 2025 First Quarter Results
-
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
-
ProcessMaker Wins Top Award as 2024 Best Generative AI Solution from SIIA CODiE
-
BlackLine, Inc. Announces Upsize and Pricing of Offering of $600,000,000 of Convertible Senior Notes
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Man Group PLC : Form 8.3 - Redrow plc
-
Man Group PLC : Form 8.3 - Quanex Building Products Corporation
-
Net Asset Value(s)
-
NIO Inc. to Report Unaudited First Quarter 2024 Financial Results on Thursday, June 6, 2024
-
VEON Receives Nasdaq Notice on Delayed Filing, Confirms Ongoing Effort to Address Auditor Appointment
-
VEON Receives Nasdaq Notice on Delayed Filing, Confirms Ongoing Effort to Address Auditor Appointment
-
Yacht Club de Monaco focuses on the future of the yachting industry
-
Form 8.5 (EPT/RI) - Touchstone Exploration Inc
-
Ensurge Micropower ASA - Registration of Share Capital Increase
-
Kim Launches Firms ‘AI Technology Use and Compliance Application’
-
Fortuna's Yaramoko Mine reaches one-million-ounce gold pour milestone
-
Aerospike a Winner in 2024 Business Sustainability Awards
-
Fortuna's Yaramoko Mine reaches one-million-ounce gold pour milestone
-
Form 8.3 - AXA INVESTMENT MANAGERS: Darktrace plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TYMAN PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Decisions of the annual general meeting of shareholders
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
-
Netcompany - Transactions in connection with share buyback programme
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Result of the auction of 2.25 per cent DGB 2026 and 2.25 per cent DGB 2033
-
Breakdown of debtors, Realkredit Danmark A/S
-
Metasphere Labs Shares Industry Developments Signaling Major Advancements in Tokenized Real World Assets
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
TRESU Investment Holding A/S – Announcement of Q1 2024 Interim Report
-
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
-
COUNSLR EXPANDS INTO RHODE ISLAND, PARTNERING WITH BRISTOL WARREN REGIONAL SCHOOL DISTRICT TO INCREASE ACCESS TO MENTAL HEALTH SUPPORT SERVICES
-
Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome
